X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (23) 23
adolescent (21) 21
child (21) 21
male (21) 21
female (19) 19
child, preschool (15) 15
transplantation (13) 13
kidney transplantation (11) 11
urology & nephrology (11) 11
treatment outcome (10) 10
adult (9) 9
cyclosporine (9) 9
calcineurin inhibitors (8) 8
kidneys (8) 8
pediatrics (8) 8
children (7) 7
infant (7) 7
focal segmental glomerulosclerosis (6) 6
health aspects (6) 6
therapy (6) 6
young adult (6) 6
genotype (5) 5
immunosuppressive agents - adverse effects (5) 5
immunosuppressive agents - therapeutic use (5) 5
pharmacology & pharmacy (5) 5
recurrence (5) 5
renal-transplantation (5) 5
risk factors (5) 5
rituximab (5) 5
alleles (4) 4
cyp3a5 (4) 4
cytochrome p-450 cyp3a - genetics (4) 4
drug administration schedule (4) 4
hemolytic-uremic syndrome (4) 4
immunosuppressive agents - pharmacokinetics (4) 4
kidney transplantation - adverse effects (4) 4
nephrotic syndrome - drug therapy (4) 4
p-glycoprotein (4) 4
proteinuria (4) 4
remission induction (4) 4
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
childhood (3) 3
cyclosporine - therapeutic use (3) 3
drug therapy, combination (3) 3
genetic polymorphisms (3) 3
immunosuppressive agents - administration & dosage (3) 3
kaplan-meier estimate (3) 3
kidney diseases (3) 3
kidney function tests (3) 3
kidney transplantation - methods (3) 3
longitudinal studies (3) 3
medicine & public health (3) 3
nephrotic syndrome (3) 3
organ transplant recipients (3) 3
pediatric kidney transplantation (3) 3
prednisone - therapeutic use (3) 3
prospective studies (3) 3
retrospective studies (3) 3
tacrolimus (3) 3
tacrolimus - pharmacokinetics (3) 3
time factors (3) 3
abcb1 (2) 2
allograft (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - adverse effects (2) 2
atypical hemolytic uremic syndrome (2) 2
bioimpedance (2) 2
blood pressure (2) 2
calcineurin - metabolism (2) 2
care and treatment (2) 2
clinical research (2) 2
complications and side effects (2) 2
cyclosporine - pharmacokinetics (2) 2
diarrhea (2) 2
diseases (2) 2
dna (2) 2
dosage and administration (2) 2
drug-metabolism (2) 2
eculizumab (2) 2
follow-up studies (2) 2
fsgs (2) 2
glomerulosclerosis (2) 2
graft rejection - diagnosis (2) 2
graft rejection - etiology (2) 2
graft survival (2) 2
hemodialysis (2) 2
hemodialysis prescription in children (2) 2
hypertension (2) 2
immunocompromised host (2) 2
immunologic diseases. allergy (2) 2
immunologic factors - therapeutic use (2) 2
immunology (2) 2
inflammatory factors (2) 2
italy (2) 2
jc virus - physiology (2) 2
kidney - drug effects (2) 2
kidney-transplantation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 06/2011, Volume 6, Issue 6, pp. 1308 - 1315
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2014, Volume 64, Issue 4, pp. 633 - 637
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 06/2019, Volume 10, p. 1332
Journal Article
Kidney International, ISSN 0085-2538, 11/2013, Volume 84, Issue 5, pp. 1025 - 1033
In children with idiopathic nephrotic syndrome, rituximab can maintain short-term remission with withdrawal of prednisone and calcineurin inhibitors. Long-term... 
clinical trial | proteinuria | nephrotic syndrome | pediatrics | CELLS | FC-GAMMA-RIIIA | IGG | MONOCLONAL-ANTIBODY | POLYMORPHISM | RESISTANT | LEUKOENCEPHALOPATHY | PEPTIDES | THERAPY | UROLOGY & NEPHROLOGY | CYCLOSPORINE | Recurrence | Sphingomyelin Phosphodiesterase - genetics | Glucocorticoids - administration & dosage | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Male | Nephrotic Syndrome - genetics | Kidney - metabolism | Receptors, IgG - genetics | Time Factors | Child | Nephrotic Syndrome - diagnosis | Glucocorticoids - adverse effects | Kidney - drug effects | Prednisone - adverse effects | Administration, Oral | Risk Factors | Rituximab | Remission Induction | Polymorphism, Genetic | Antigens, CD20 - genetics | Nephrotic Syndrome - immunology | Adolescent | Antibodies, Monoclonal, Murine-Derived - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Glucocorticoids - therapeutic use | Phosphorylation | Age Factors | Kidney - immunology | Nephrotic Syndrome - drug therapy | Calcineurin Inhibitors | src-Family Kinases - metabolism | Female | Immunosuppressive Agents - administration & dosage | Prednisone - administration & dosage | Podocytes - metabolism | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Antigens, CD20 - metabolism | Podocytes - drug effects | Podocytes - immunology | Immunosuppressive Agents - adverse effects | Infusions, Intravenous | Calcineurin - metabolism
Journal Article
CLINICAL NEPHROLOGY, ISSN 0301-0430, 10/2018, Volume 90, Issue 4, pp. 286 - 290
Journal Article
Pediatrics, ISSN 0031-4005, 06/2014, Volume 133, Issue 6, pp. e1769 - e1771
Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease often related to uncontrolled complement activation. The use of eculizumab has... 
End-stage renal disease | Hemolitic uremic syndrome | Proteinuria | hemolitic uremic syndrome | PEDIATRICS | COMPLEMENT | end-stage renal disease | proteinuria | Plasma | Humans | Child, Preschool | Infant | Male | Secondary Prevention | Haptoglobins - metabolism | Kidney Function Tests | Hemolytic-Uremic Syndrome - genetics | DNA Mutational Analysis | Purpura, Thrombotic Thrombocytopenic - drug therapy | Hemolytic-Uremic Syndrome - diagnosis | Proteinuria - diagnosis | Child | Purpura, Thrombotic Thrombocytopenic - genetics | Complement Activation - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Complement Factor H - immunology | Diagnosis, Differential | Antibodies, Monoclonal, Humanized - therapeutic use | Proteinuria - immunology | Combined Modality Therapy | Biomarkers - blood | Proteinuria - genetics | Purpura, Thrombotic Thrombocytopenic - diagnosis | Hemolytic-Uremic Syndrome - immunology | Plasmapheresis | Platelet Count | Proteinuria - drug therapy | L-Lactate Dehydrogenase - blood | Purpura, Thrombotic Thrombocytopenic - immunology | Complement Factor H - genetics | Longitudinal Studies | Hemolytic-Uremic Syndrome - drug therapy | Complications and side effects | Care and treatment | Monoclonal antibodies | Kidney diseases | Health aspects | Risk factors | Hemolytic-uremic syndrome | Disease prevention | Mutation | Medical treatment
Journal Article
Journal Article
Journal of Nephrology, ISSN 1121-8428, 2/2018, Volume 31, Issue 1, pp. 37 - 45
Focal and segmental glomerulosclerosis (FSGS) is a histological pattern clinically characterized by nephrotic proteinuria, hypoalbuminemia, edema and... 
Podocyte | Therapy | Nephrology | Focal and segmental glomerulosclerosis | Medicine & Public Health | Nephrotic syndrome | Urology | CLINICAL-TRIAL | RENAL-FUNCTION | RANDOMIZED-TRIAL | GLOMERULAR SCLEROSIS | DIRECT TARGET | TUMOR-NECROSIS-FACTOR | FSGS | UROLOGY & NEPHROLOGY | TNF-ALPHA | MYCOPHENOLATE-MOFETIL
Journal Article
European Journal of Pediatrics, ISSN 0340-6199, 4/2016, Volume 175, Issue 4, pp. 465 - 473
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 06/2012, Volume 23, Issue 6, pp. 1117 - 1124
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 03/2018, Volume 33, Issue 3, p. 542
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 09/2012, Volume 84, Issue 9, pp. 1464 - 1470
Rituximab is a chimeric monoclonal antibody reacting with the CD20 antigen on B cells. It has been proposed as treatment for the idiopathic nephrotic syndrome,... 
polyomavirus | monoclonal antibody | children | nephrotic syndromes | Nephrotic syndromes | Children | Monoclonal antibody | Polyomavirus | DEPENDENT NEPHROTIC SYNDROME | VARIANTS | NONCODING CONTROL REGION | B-CELL DEPLETION | JC VIRUS-DNA | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | VIROLOGY | TRANSCRIPTIONAL CONTROL REGION | SEQUENCE | NON-HODGKINS-LYMPHOMA | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Nephrotic Syndrome - urine | Tumor Virus Infections - virology | Humans | Regulatory Sequences, Nucleic Acid | Child, Preschool | Male | JC Virus - physiology | Polyomavirus Infections - blood | Molecular Typing | Tumor Virus Infections - urine | Tumor Virus Infections - blood | Female | Child | Virus Activation | JC Virus - genetics | Rituximab | Viral Proteins - genetics | BK Virus - genetics | Genotype | DNA, Viral - urine | Sequence Analysis, DNA | DNA, Viral - blood | Polyomavirus Infections - urine | Nephrotic Syndrome - virology | Virus Replication | Polyomavirus Infections - virology | Adolescent | Nephrotic Syndrome - blood | Antibodies, Monoclonal, Murine-Derived - pharmacology | BK Virus - physiology | Longitudinal Studies | Immunologic Factors - pharmacology | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Kidney Transplantation - adverse effects | Virus diseases | Pediatrics | Chemotherapy | Biological products | Viral proteins | Kidney diseases | T cells | Health aspects | Cancer | Monoclonal antibodies | Drug therapy | Antiviral drugs | Virology
Journal Article
Pharmacogenomics, ISSN 1462-2416, 04/2015, Volume 16, Issue 5, pp. 483 - 491
Journal Article